DK571484A - Substituerede ethylendiaminderivater samt deres fremstilling og anvendelse - Google Patents

Substituerede ethylendiaminderivater samt deres fremstilling og anvendelse Download PDF

Info

Publication number
DK571484A
DK571484A DK571484A DK571484A DK571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A DK 571484 A DK571484 A DK 571484A
Authority
DK
Denmark
Prior art keywords
ethylendiamine
derivatives
substituted
preparation
substituted ethylendiamine
Prior art date
Application number
DK571484A
Other languages
Danish (da)
English (en)
Other versions
DK571484D0 (da
Inventor
Vittorio Rasetti
Peter Buehlmayer
Walter Fuhrer
Rudolf Heinrich Andreatta
Anthony Caselli
Ulrich Renner
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK571484D0 publication Critical patent/DK571484D0/da
Publication of DK571484A publication Critical patent/DK571484A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK571484A 1983-12-01 1984-11-30 Substituerede ethylendiaminderivater samt deres fremstilling og anvendelse DK571484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH643683 1983-12-01

Publications (2)

Publication Number Publication Date
DK571484D0 DK571484D0 (da) 1984-11-30
DK571484A true DK571484A (da) 1985-06-02

Family

ID=4309613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK571484A DK571484A (da) 1983-12-01 1984-11-30 Substituerede ethylendiaminderivater samt deres fremstilling og anvendelse

Country Status (6)

Country Link
EP (1) EP0144290A3 (fr)
JP (1) JPS60136595A (fr)
AU (1) AU3609484A (fr)
DK (1) DK571484A (fr)
ES (1) ES8701142A1 (fr)
GR (1) GR81124B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88400C (fi) * 1984-08-06 1993-05-10 Upjohn Co Foerfarande foer framstaellning av renin inhiberande peptider
JPH05501879A (ja) * 1989-10-27 1993-04-08 ジ・アップジョン・カンパニー Hivおよび他のレトロウイルスを処理する方法およびそれに有用な化合物
FR2711990B1 (fr) * 1993-11-05 1995-12-08 Exsymol Sa Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
WO1996004244A1 (fr) * 1994-08-05 1996-02-15 Warwick International Group Limited Activateurs de blanchiment
JP4484897B2 (ja) * 1995-12-08 2010-06-16 生化学工業株式会社 アミノアルコール誘導体の製造方法
GB9727123D0 (en) * 1997-12-22 1998-02-25 Int Centre Genetic Eng & Bio Synthesis of diamines
AU6075400A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-substituted glycine derivatives
WO2005113582A1 (fr) * 2004-05-22 2005-12-01 Boehringer Ingelheim International Gmbh Ethane-1,2-diamines substituees pour le traitement de la maladie d'alzheimer
JP2008519840A (ja) 2004-11-10 2008-06-12 ジェンザイム・コーポレイション 糖尿病の処置方法
JP5042040B2 (ja) * 2005-01-26 2012-10-03 アラーガン、インコーポレイテッド 鎮痛活性および/または免疫賦活活性を有する1−アリール−1−ヒドロキシ−2,3−ジアミノ−プロピルアミン、1−ヘテロアリール−1−ヒドロキシ−2,3−ジアミノ−プロピルアミンおよび関連化合物
ES2546181T3 (es) 2006-05-09 2015-09-21 Genzyme Corporation Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos
EP2167485B1 (fr) * 2007-05-31 2015-09-30 Genzyme Corporation Inhibiteurs de glucosylcéramide synthase de type 2-acylaminopropanol
MX2010003603A (es) 2007-10-05 2010-06-02 Genzyme Corp Metodo para el tratamiento de enfermedades de riñon poliquisticas con derivados de ceramida.
CA2731685A1 (fr) 2008-07-28 2010-02-04 Genzyme Corporation Inhibition de synthase de glucosylceramide pour le traitement du glomerulopathie avec collapsus, et d'un autre trouble glomerulaire
MX2011003517A (es) 2008-10-03 2011-05-25 Genzyme Corp Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol.
JP2020532562A (ja) * 2017-09-05 2020-11-12 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 生物学的製剤の粘度を低下させるための化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198398A (en) * 1977-07-12 1980-04-15 Derek Hudson Enkephalin analogues
US4145337A (en) * 1977-10-11 1979-03-20 Hoffmann-La Roche Inc. Aminoethylglycine containing polypeptides
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1245217A (fr) * 1981-12-10 1988-11-22 Joshua S. Boger Peptides inhibiteurs de la renine
EP0316965A3 (fr) * 1983-02-07 1989-08-09 Aktiebolaget Hässle Inhibiteurs d'enzymes
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres

Also Published As

Publication number Publication date
ES8701142A1 (es) 1986-11-16
AU3609484A (en) 1985-06-06
EP0144290A2 (fr) 1985-06-12
ES538172A0 (es) 1986-11-16
JPS60136595A (ja) 1985-07-20
EP0144290A3 (fr) 1987-05-27
GR81124B (en) 1985-03-26
DK571484D0 (da) 1984-11-30

Similar Documents

Publication Publication Date Title
DK554784A (da) Substituerede 5-amino-4-hydroxyvalerylderivater samt deres fremstilling og anvendelse
DK559985A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK211582A (da) Arylphenylether-derivater samt deres fremstilling og anvendelse
DK289886A (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK410384D0 (da) N-(2-nitrophenyl)-4-aminopyrimidin-derivater samt deres fremstilling og anvendelse
DK41484A (da) Beta-phenethanolaminer og deres anvendelse
DK317588A (da) 2-anilino-pyrimidin-derivat samt deres fremstilling og anvendelse
DK571484D0 (da) Substituerede ethylendiaminderivater samt deres fremstilling og anvendelse
DK578185A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK614084D0 (da) Milbemycim-derivater samt deres fremstilling og anvendelse
DK35884D0 (da) Lactampeptider samt deres fremstilling og anvendelse
DK614384D0 (da) Substituerede imidazoler samt deres fremstilling og anvendelse
DK294684D0 (da) N-alkylerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK45188A (da) Substituerede aminderivater og deres anvendelse
DK297082A (da) Substituerede 1-azolyl-2-hydroxy-alkanderivater samt deres fremstilling og anvendelse
DK558484D0 (da) Milbemycinderivater samt deres fremstilling og anvendelse
DK537785A (da) Flavolignanderivater samt deres fremstilling og anvendelse
DK297182A (da) Substituerede 2-hydroxy-3-azolyl-propanderivater samt deres fremstilling og anvendelse
DK189584D0 (da) (5alfa)-20-spirox-1-en-3-oner samt deres fremstilling og anvendelse
DK419084A (da) 2-aminomethyl-2-penem-forbindelser samt deres fremstilling og anvendelse
DK393285A (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK236585A (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK35984D0 (da) Lactampeptider samt deres fremstilling og anvendelse
DK422685D0 (da) Benzazolderivater samt deres fremstilling og anvendelse
DK153285D0 (da) Benzodioxolderivater samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment